NCT00426829View on ClinicalTrials.gov

Proton Therapy and Bevacizumab for Primary Liver Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Liver CancerHepatocellular CarcinomaCholangiocarcinoma
Interventions
DRUG

Bevacizumab

10 mg/kg by vein every 14 days +/- 2 days, starting on day 1.

RADIATION

Proton Radiation Therapy

3 Gy dose/fraction x 20 fractions.

Trial Locations (1)

77030

U.T. M.D. Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER